Skip to main content
Log in

Cycloxygenase-2 is Essential for the Survival and Proliferation of Gastric Cancer Cells

  • Original Paper
  • Published:
Cell Biochemistry and Biophysics Aims and scope Submit manuscript

Abstract

Cycloxygenase-2 catalyzes the synthesis of prostaglandins from arachidonic acid and this enzyme has been implicated in the metastasis of gastric cancer. In order to examine the significance of cycloxygenase-2 (Cox-2) in the survival and proliferation of gastric cancer cells, we have stably overexpressed an antisense Cox-2 in two gastric cancer cell lines, SGC7901 and AGS, in order to reduce the expression of this protein. The sense and antisense Cox-2 expression vectors were created by cloning COX-2 cDNA, in pIRES2-EGFP plasmid. Cox-2 gene expression was monitored by RT-PCR and Western blotting and the results indicated that cells with antisense Cox-2 construct had significantly reduced Cox-2 expression in comparison to the cells that received sense-Cox-2 plasmid. Reduction of Cox-2 expression in SGC7901 and AGS gastric cancer cells led to markedly decreased proliferation. The metastatic capability of the two cell lines, as assessed by in vitro colony formation assay, is also significantly compromised by lowered Cox-2 expression. Thus, this study demonstrates that Cox-2 activity is necessary for the proliferation and metastasis of gastric cancer cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Wu, K., Nie, Y., Guo, C., Chen, Y., Ding, J., et al. (2009). Molecular basis of therapeutic approaches to gastric cancer. Journal of Gastroenterology and Hepatology, 24, 37–41.

    Article  PubMed  CAS  Google Scholar 

  2. Agarwal, S., Reddy, G. V., & Reddanna, P. (2009). Eicosanoids in inflammation and cancer: The role of COX-2. Expert Review of Clinical Immunology, 5, 145–165.

    Article  PubMed  CAS  Google Scholar 

  3. Sugiyama, T., Yoshimoto, T., Sato, R., Fukai, N., Ozawa, N., et al. (2004). Endothelin-1 induces cyclooxygenase-2 expression and generation of reactive oxygen species in endothelial cells. Journal of Cardiovascular Pharmacology, 44(Suppl 1), S332–S335.

    Article  PubMed  CAS  Google Scholar 

  4. Wang, D., & Dubois, R. N. (2006). Prostaglandins and cancer. Gut, 55, 115–122.

    Article  PubMed  CAS  Google Scholar 

  5. Patrignani, P., Tacconelli, S., Sciulli, M. G., & Capone, M. L. (2005). New insights into COX-2 biology and inhibition. Brain Research Reviews, 48, 352–359.

    Article  PubMed  CAS  Google Scholar 

  6. Samad, T. A., Moore, K. A., Sapirstein, A., Billet, S., Allchorne, A., et al. (2001). Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature, 410, 471–475.

    Article  PubMed  CAS  Google Scholar 

  7. Stratford, I. J., & Stephens, M. A. (1989). The differential hypoxic cytotoxicity of bioreductive agents determined in vitro by the MTT assay. International Journal of Radiation Oncology, Biology, Physics, 16, 973–976.

    Article  PubMed  CAS  Google Scholar 

  8. Garcia-Rodriguez, L. A., & Huerta-Alvarez, C. (2001). Reduced risk of colorectal cancer among long-term users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs. Epidemiology, 12, 88–93.

    Article  PubMed  CAS  Google Scholar 

  9. Prescott, S. M., & Fitzpatrick, F. A. (2000). Cyclooxygenase-2 and carcinogenesis. Biochimica et Biophysica Acta, 1470, M69–M78.

    PubMed  CAS  Google Scholar 

  10. Wu, W. K., Cho, C. H., Lee, C. W., Fan, D., Wu, K., et al. (2010). Dysregulation of cellular signaling in gastric cancer. Cancer Letters, 295, 144–153.

    Article  PubMed  CAS  Google Scholar 

  11. Jimenez, P., Garcia, A., Santander, S., & Piazuelo, E. (2007). Prevention of cancer in the upper gastrointestinal tract with COX-inhibition. Still an option? Current Pharmaceutical Design, 13, 2261–2273.

    Article  PubMed  CAS  Google Scholar 

  12. Kojima, M., Morisaki, T., Izuhara, K., Uchiyama, A., Matsunari, Y., et al. (2000). Lipopolysaccharide increases cyclo-oxygenase-2 expression in a colon carcinoma cell line through nuclear factor-kappa B activation. Oncogene, 19, 1225–1231.

    Article  PubMed  CAS  Google Scholar 

  13. Chell, S., Kaidi, A., Williams, A. C., & Paraskeva, C. (2006). Mediators of PGE2 synthesis and signalling downstream of COX-2 represent potential targets for the prevention/treatment of colorectal cancer. Biochimica et Biophysica Acta, 1766, 104–119.

    PubMed  CAS  Google Scholar 

  14. Chiba, T., & Marusawa, H. (2009). A novel mechanism for inflammation-associated carcinogenesis; an important role of activation-induced cytidine deaminase (AID) in mutation induction. Journal of Molecular Medicine, 87, 1023–1027.

    Article  PubMed  CAS  Google Scholar 

  15. Oguma, K., Oshima, H., & Oshima, M. (2010). Inflammation, tumor necrosis factor and Wnt promotion in gastric cancer development. Future Oncology, 6, 515–526.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hua Yang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ma, D., Liu, M., Wang, AP. et al. Cycloxygenase-2 is Essential for the Survival and Proliferation of Gastric Cancer Cells. Cell Biochem Biophys 61, 637–641 (2011). https://doi.org/10.1007/s12013-011-9249-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12013-011-9249-6

Keywords

Navigation